General Public Policy Exceptions in International Investment Agreements (IIAs): Opportunities and Challenges in Times of Global Health Crisis
PhD in School of International Law, Chinese University of Political Science and Law, major in International Economic Law
摘要
The COVID-19 has been going on for more than three years now and the impact on global trade has been catastrophic. Nowadays, in the face of the normalization of the pandemic, some countries have in fact gradually found viable ways to balance the health of their citizens with economic recovery, and the global economy is expected to be rebuilt. But this picture of a trade-off between public health and economic and trade development was virtually non-existent at the beginning of the outbreak, and even long afterwards. Faced with the ravages of the pandemic, many countries adopted a series of measures that excessively restricted trade. While these measures may have had the effect of “isolating” the pandemic for a short period of time, the impact on trade and the economy can be enormous and ultimately detrimental to the prevention and control of the pandemic. Article 43 of the International Health Regulations (2005) (hereinafter “the Regulations”) specifically provides for a mechanism of “additional health measures” to regulate the use of excessive trade-restrictive measures by States Parties. However, past practice in dealing with infectious diseases has shown that States Parties have often breached this provision. Affected States Parties also prefer to apply the SPS Agreement to seek redress from the WTO dispute settlement mechanism rather than using the corresponding provisions of the Regulation. Why does the existing Article 43 not prevent Member States from taking excessive measures? Why has the “additional health measures” mechanism been “left out”? How can countries properly use their “autonomy” to adopt “additional health measures”? In order to effectively prevent countries from taking excessive trade-restrictive measures and to maximize the balance between trade and health during outbreaks of infectious diseases, this paper will reflect on and examine the issues related to the “additional health measures” mechanism in the light of the current situation of the spread of the COVID-19. The first chapter analyses the normative and application dilemmas of the “additional health measures” mechanism; the second chapter explores the causes of the dilemmas of the “additional health measures” mechanism; and finally, some thoughts on improving the mechanism of “additional health measures” are presented.
Abstract
The COVID-19 has been going on for more than three years now and the impact on global trade has been catastrophic. Nowadays, in the face of the normalization of the pandemic, some countries have in fact gradually found viable ways to balance the health of their citizens with economic recovery, and the global economy is expected to be rebuilt. But this picture of a trade-off between public health and economic and trade development was virtually non-existent at the beginning of the outbreak, and even long afterwards. Faced with the ravages of the pandemic, many countries adopted a series of measures that excessively restricted trade. While these measures may have had the effect of “isolating” the pandemic for a short period of time, the impact on trade and the economy can be enormous and ultimately detrimental to the prevention and control of the pandemic. Article 43 of the International Health Regulations (2005) (hereinafter “the Regulations”) specifically provides for a mechanism of “additional health measures” to regulate the use of excessive trade-restrictive measures by States Parties. However, past practice in dealing with infectious diseases has shown that States Parties have often breached this provision. Affected States Parties also prefer to apply the SPS Agreement to seek redress from the WTO dispute settlement mechanism rather than using the corresponding provisions of the Regulation. Why does the existing Article 43 not prevent Member States from taking excessive measures? Why has the “additional health measures” mechanism been “left out”? How can countries properly use their “autonomy” to adopt “additional health measures”? In order to effectively prevent countries from taking excessive trade-restrictive measures and to maximize the balance between trade and health during outbreaks of infectious diseases, this paper will reflect on and examine the issues related to the “additional health measures” mechanism in the light of the current situation of the spread of the COVID-19. The first chapter analyses the normative and application dilemmas of the “additional health measures” mechanism; the second chapter explores the causes of the dilemmas of the “additional health measures” mechanism; and finally, some thoughts on improving the mechanism of “additional health measures” are presented.
關鍵詞
- 類型
- 論文
- 期刊
- Asian Journal of WTO & International Health Law and policy
- ISSN
- 1819-5164
- 卷期
- 20卷1期
- 出版
- 2025年03月
- 頁碼
- 177–208
- 編號
- NTUEJ00000019
同期目錄
- The Application of International Climate Change Law in International Investment Arbitration: Addressing the DeficienciesSheng Zhang & Ni Li・頁 1–40
- Unveiling Data as an Investment in International Investment Law: China’s Quest towards Harmonious Adaptation and Developmental ParadigmsXinlong Yang・頁 41–90
- Anti-Enforcement Loops of Renewable Energy Awards Against Spain: Risks and Anti-AbuseLiping Huang・頁 91–126
- How to Balance International Trade and Public Health in the Face of Emerging Infectious Diseases? — Reflections and Research Based on the Implementation of “Additional Health Measures” in COVID-19Yi Tang・頁 127–176
- General Public Policy Exceptions in International Investment Agreements (IIAs): Opportunities and Challenges in Times of Global Health CrisisJiabao Duan・頁 177–208
- Looking Outside or Looking Inside?: The Effects of Trade Bureaucracy Design on Trade Dispute BehaviorJung Hyun Han & RyuGyung Park・頁 209–248